- Home
- PBM vs LCFY Comparison
PBM vs LCFY Comparison
Compare PBM & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBM
- LCFY
- Stock Information
- Founded
- PBM 1994
- LCFY 2009
- Country
- PBM Canada
- LCFY Australia
- Employees
- PBM N/A
- LCFY N/A
- Industry
- PBM
- LCFY
- Sector
- PBM
- LCFY
- Exchange
- PBM NYSE
- LCFY Nasdaq
- Market Cap
- PBM 7.5M
- LCFY 7.3M
- IPO Year
- PBM N/A
- LCFY 2022
- Fundamental
- Price
- PBM $1.79
- LCFY $8.50
- Analyst Decision
- PBM
- LCFY
- Analyst Count
- PBM 0
- LCFY 0
- Target Price
- PBM N/A
- LCFY N/A
- AVG Volume (30 Days)
- PBM 5.4M
- LCFY 23.2K
- Earning Date
- PBM 02-02-2025
- LCFY 11-12-2024
- Dividend Yield
- PBM N/A
- LCFY N/A
- EPS Growth
- PBM N/A
- LCFY N/A
- EPS
- PBM N/A
- LCFY N/A
- Revenue
- PBM N/A
- LCFY $2,668,385.00
- Revenue This Year
- PBM N/A
- LCFY N/A
- Revenue Next Year
- PBM N/A
- LCFY N/A
- P/E Ratio
- PBM N/A
- LCFY N/A
- Revenue Growth
- PBM N/A
- LCFY N/A
- 52 Week Low
- PBM $1.51
- LCFY $2.20
- 52 Week High
- PBM $593.25
- LCFY $11.23
- Technical
- Relative Strength Index (RSI)
- PBM 39.22
- LCFY 60.26
- Support Level
- PBM $1.61
- LCFY $6.78
- Resistance Level
- PBM $2.25
- LCFY $10.54
- Average True Range (ATR)
- PBM 0.22
- LCFY 0.68
- MACD
- PBM 0.06
- LCFY 0.09
- Stochastic Oscillator
- PBM 23.38
- LCFY 48.87
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has three operating segments: the Publishing segment, the Reseller segment, and the Channel sales segment. It derives a majority of its revenue from Australia and New Zealand.